FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, namely to production of an agent for treatment and prevention of periodontium and mouth mucosa diseases. The agent is composed of gooseberry marc oil, eucalyptus, mineral oil, chlorhexidine bigluconate, sodium carboxymethyl cellulose, methylparabene, propylparabene, water.
EFFECT: agent extends the range of the preparations applied for treatment and prevention of inflammatory processes of the periodontium and mouth mucosa, promotes faster cicatrisation of parodontal pockets, and exhibits a high therapeutic outcome.
2 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DENTAL GEL | 2022 |
|
RU2806865C1 |
| METHOD OF TREATING CHRONIC GENERALISED PERIODONTITIS | 2013 |
|
RU2550970C2 |
| METHOD OF INTEGRATED TREATMENT OF PATIENTS WITH INFLAMMATORY PERIODONTAL DISEASES | 2015 |
|
RU2605260C1 |
| COMPOSITION IN FORM OF GEL FOR ORAL TISSUES CARE | 2020 |
|
RU2733718C1 |
| AGENT FOR TREATMENT OF PARODONTIUM DISEASES | 2007 |
|
RU2361600C1 |
| DENTAL GEL FOR TREATMENT OF INFLAMMATORY DISEASES OF PERIODONTAL AND MUCOSA OF ORAL CAVITY, ARISING ON BACKGROUND OF PSYCHOEMOTIONAL STRESS | 2021 |
|
RU2754828C1 |
| DENTAL STICK FOR TREATING INFLAMMATORY PERIODONTAL DISEASES | 2011 |
|
RU2466707C1 |
| DENTAL GEL WITH A PHYTOPELOID COMPOSITION | 2019 |
|
RU2699560C1 |
| DENTAL GEL WITH CHLORHEXIDINE AND DIBUNOLE FOR TREATMENT OF INFLAMMATORY DISEASES OF PARODENTIUM AND ORAL CAVITY MUCOSA | 2010 |
|
RU2420257C1 |
| OINTMENT WITH METRONIDAZOLE, BEE MOTH LARVAE EXTRACT AND ANAESTHESINE FOR INTEGRATED TREATMENT OF INFLAMMATORY PERIODONTAL DISEASES | 2014 |
|
RU2564944C1 |
